https://www.selleckchem.com/pr....oducts/dl-ap5-2-apv.
Furthermore, Exos reached the substantia nigra through the blood-brain barrier (BB in vivo, relieved apomorphine-induced asymmetric rotation, reduced substantia nigra dopaminergic neuron loss and apoptosis, and upregulated the level of dopamine in the striatum. These results demonstrate that hucMSCs-Exos have a treatment capability for PD and can traverse the BBB, indicating their potential for the effective treatment of PD.Recent studies portend a rising global spread and adaptation of human- or healthcare-associated pathogens.
Like
Comment
Share
